Replies to post #509594 on Anavex Life Sciences Corp (AVXL)

[oldmystic]

It seems likely Anavex will be approved at re-eval with a narrower indication

How likely?
With all due respect.

[Investor2014]

If your assessment were always based on the ABCLEAR1 subgroup, and assuming replacing ADL with Sum of Boxes was in the SAP, then why did that not lead to a positive opinion? Something else must be putting a spanner in the works - what do you think that might be?

[AlchemicalVoyager13]

Mayo: While you do a high level of research your projections well into the high hundreds of dollars per share are fantasy. You do not consider competition for example, and I am meaning other potential oral treatments from the likes of Annovis and Cognition Therapeutics, which is for Tau 217 really. Furthermore, to consider JnJ when they have a huge product line that is non-drug for P/E is not reasonable. Furthermore, companies that are established with predicable earnings carry a lot more weight than a one trick pony. Your numbers are ridiculous, sorry, but they are. IF we get approved it will be for WT only in all likelihood and conditional. CGTX has a reasonable chance of surpassing our market cap inside two years by leaps and bounds. You may know pharmacology but your business acumen is lacking.

[BAR123]

Mayo, good luck tomorrow. Please ask the tough questions and don't succumb to the company asking you to feed them softballs like the other 2 analysts. I've had enough of BS conf calls because the company cannot attract top tier analysts on the call. So we are stuck with the guy who can't take the phone off mute and when he figures that out he stumbles out a non relevant question. You on the other hand have an opportunity to hold their feet to the fire. We need distinct information on the path forward for the EMA, where we truly stand with a partner and what the FDA is doing with us. Personally I think if Missling goes about this the same way he has in the past, it will be very bad and I see us going into the $2 range. Maybe back up the truck area and hope for the best but I believe we are in a desperate spot as a company. We need something big to happen. We do not have the cash to do a large 1K person trial in the USA unless he sold10M shares in the $10 range a few months ago. Even if he did that, it will take 2.5 - 3 years to get results and we will be dead in the water. That needs to come out as well.

Ask him about shareholder value he should be creating. Ask him why after producing the greatest results ever seen for Alzheimer's , that we are sitting close to a 11 year low. WHY DOESN"T WALL STREET BELIEVE HIM? Having a credible CEO is key to success. He has none.

The company needs strategic thinking people for Wall Street. Bump Missling to Chairman and bring in a top tier pharma President/CEO.